APAC Intravascular Lithotripsy Market Industry Trends and Forecast to 2034: Segmented by (Application, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
APAC · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$210.1 MnPlaceholder estimate
Estimate 2025$259.4 Mn21.8% of the global market
Projected 2034$1.73 Bn 568.3%Adds $1.47 Bn over 9 forecast years
CAGR 2025–203423.5%Faster than 95% of 173 Medical Devices markets here
Key players5
APAC is 21.79% of the global market.
Among regions, the largest is North America at $545.0 Mn.
Fastest growing: APAC (this report) at 23.5% a year.
APAC ranks 2nd of 6 by size among regions.
Market size projection
APAC
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$1.47 Bn total, 2026–2034
Year-by-year market size, 2024–2034
Intravascular Lithotripsy Market market size by year, APAC
Year
Market size
Change that year
Since 2025
2024 (estimate)
$210.1 Mn
—
—
2025 (base)
$259.4 Mn
+$49.4 Mn
—
2026 (forecast)
$320.4 Mn
+$61.0 Mn
+23.5%
2027 (forecast)
$395.7 Mn
+$75.3 Mn
+52.5%
2028 (forecast)
$488.7 Mn
+$93.0 Mn
+88.4%
2029 (forecast)
$603.5 Mn
+$114.8 Mn
+132.6%
2030 (forecast)
$745.4 Mn
+$141.8 Mn
+187.3%
2031 (forecast)
$920.5 Mn
+$175.2 Mn
+254.8%
2032 (forecast)
$1.14 Bn
+$216.3 Mn
+338.2%
2033 (forecast)
$1.40 Bn
+$267.2 Mn
+441.2%
2034 (forecast)
$1.73 Bn
+$329.9 Mn
+568.3%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Shockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical, Amplitude Vascular (see all)
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The APAC Intravascular Lithotripsy Market Analysis Executive Summary
Intravascular lithotripsy uses sound waves inside an artery to crack hard calcium, making it easier to place stents.
Key segments of the intravascular Lithotripsy market include application (Coronary, Peripheral and Aortic Access) and product (Catheters and Generators).
Asia Pacific Intravascular Lithotripsy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
APAC Intravascular Lithotripsy Market Dynamics
Market Growth Drivers
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.
Opportunity
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the intravascular Lithotripsy market room to grow.
Market Restraints
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the intravascular Lithotripsy market.
Competitive Landscape for Intravascular Lithotripsy Market in APAC
The intravascular Lithotripsy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Intravascular Lithotripsy Market in APAC
Intravascular Lithotripsy in APAC: rules and payment
In some of the countries we cover here, medical devices are regulated by TGA (Australia)[1], NMPA (China)[2], MDACS (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], MDA (Malaysia)[6], Medsafe (WAND) (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10]. How care is paid for in some of these countries: Medicare and the PBS (Australia)[11], basic medical insurance (China)[12], the Hospital Authority (Hong Kong)[13], Ayushman Bharat PM-JAY (India)[14], public health insurance (Japan)[15], subsidised public care (Malaysia)[16], Pharmac (New Zealand)[17], PhilHealth (Philippines)[18], MediShield Life (Singapore)[19] and the Universal Coverage Scheme (Thailand)[20].
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intravascular Lithotripsy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Application
4.2 By Product
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Shockwave Medical (Johnson & Johnson)
7.2 Boston Scientific
7.3 Abbott Laboratories
7.4 FastWave Medical
7.5 Amplitude Vascular
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The intravascular Lithotripsy market can be segmented based on various criteria, including application, product and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Intravascular Lithotripsy right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
WHO Global Health Observatory.
Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Intravascular Lithotripsy market in Asia Pacific?
Placeholder estimate: about $259.4 Mn in 2025, rising to about $1.73 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Intravascular Lithotripsy market in Asia Pacific growing?
Placeholder estimate: about 23.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Intravascular Lithotripsy market report cover?
The report splits the market by application (Coronary, Peripheral, Aortic Access), product (Catheters, Generators) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Intravascular Lithotripsy market?
Key players include Shockwave Medical (Johnson & Johnson), Boston Scientific Corporation, Abbott Laboratories, FastWave Medical and Amplitude Vascular.
What is driving the Intravascular Lithotripsy market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the intravascular Lithotripsy market.
How much research is published on Intravascular Lithotripsy?
PubMed lists 854 papers on Intravascular Lithotripsy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.